KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models

BACKGROUND: In non-small cell lung cancer (NSCLC) KRAS-mutant status is a negative prognostic and predictive factor. Nitrogen-containing bisphosphonates inhibit prenylation of small G-proteins (e.g. Ras, Rac, Rho) and thus may affect proliferation and migration. In our preclinical work, we investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenessey, István, Kói, Krisztina, Horváth, Orsolya, Cserepes, Mihály, Molnár, Dávid, Izsák, Vera, Dobos, Judit, Hegedűs, Balázs, Tóvári, József, Tímár, József
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346731/
https://www.ncbi.nlm.nih.gov/pubmed/27780929
http://dx.doi.org/10.18632/oncotarget.12806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346731/
https://www.ncbi.nlm.nih.gov/pubmed/27780929
http://dx.doi.org/10.18632/oncotarget.12806

Ejemplares similares